BELLUS Health
BLU
$14.74
Share price
0.00%
Change (1 day)
47.70%
Change (1 year)
Categories
P/S ratio for BELLUS Health (BLU)
P/S ratio as of May 2024 (TTM): > 1000
According to BELLUS Health's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 124614. At the end of 2023 the company had a P/S ratio of > 1000.
P/S ratio history for BELLUS Health from 2021 to 2019
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | > 1000 | -6.53% |
| 2022 | > 1000 | 26.16% |
| 2021 | > 1000 | |
| 2019 | > 1000 | 240.21% |
| 2018 | > 1000 | 1645.87% |
| 2017 | 345 | 2752.71% |
| 2016 | 12.1 | -24.06% |
| 2015 | 15.9 | -48.73% |
| 2014 | 31.0 | 254.65% |
| 2013 | 8.75 | 4.58% |
| 2012 | 8.36 | 197.71% |
| 2011 | 2.81 | -70.28% |
| 2010 | 9.45 | |
| 2009 | N/A | -100% |
| 2008 | 35.6 | -53.23% |
| 2007 | 76.2 | -78.16% |
| 2006 | 349 | 53.29% |
| 2005 | 228 | |
| 2003 | 272 | 24.96% |
| 2002 | 218 | 1751.62% |
| 2001 | 11.8 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |